Chu D, Stephenson B, Lee J, Bannister B, Hickey C, Westley T, Zirwas M. Clinical Efficacy and Patient Reported Impacts of Roflumilast Foam 0.3% in Seborrheic Dermatitis: An Analysis of STRATUM Data for Patients Unresponsive or Intolerant to Topical Corticosteroids. J of Skin [Internet]. 2024Mar.18 [cited 2025Jan.10];8(2):s397. Available from: https://skin.dermsquared.com/skin/article/view/2589